Dana-Farber chief Laurie Glimcher set to leave storied cancer center

After eight years, Laurie Glimcher will step down as president and CEO of the Dana-Farber Cancer Institute, Boston’s famed oncology research center.

Replacing her on …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

7wireVentures Launches $217M Growth & Opportunity Fund

What You Should Know: – 7wireVentures, one of the country’s leading digital health venture capital firms, today announced the successful completion of a $217 million

October 3, 2023

A Twice-Yearly Shot Could Help End AIDS. But Will It Get to Everyone Who Needs It?

It’s been called the closest the world has ever come to a vaccine against HIV. The twice-yearly shot was 100% effective in preventing HIV infections

December 3, 2024

Which drugs are most likely to be approved in Choroidal Disease?

Choroidal Disease disease is an indication for drug development with over 40 pipeline drugs currently active according to GlobalData.

March 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.